Cargando…

Lead-exposure associated miRNAs in humans and Alzheimer’s disease as potential biomarkers of the disease and disease processes

Alzheimer’s disease (AD) is a neurodegenerative disease that eventually affects memory and behavior. The identification of biomarkers based on risk factors for AD provides insight into the disease since the exact cause of AD remains unknown. Several studies have proposed microRNAs (miRNAs) in blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Qingfeng, Verheijen, Marcha, Wittens, Mandy Melissa Jane, Czuryło, Julia, Engelborghs, Sebastiaan, Hauser, Duncan, van Herwijnen, Marcel H. M., Lundh, Thomas, Bergdahl, Ingvar A., Kyrtopoulos, Soterios A., de Kok, Theo M., Smeets, Hubert J. M., Briedé, Jacco Jan, Krauskopf, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509380/ https://www.ncbi.nlm.nih.gov/pubmed/36153426 http://dx.doi.org/10.1038/s41598-022-20305-5

Ejemplares similares

Blood Transcriptome Response to Environmental Metal Exposure Reveals Potential Biological Processes Related to Alzheimer's Disease
por: Krauskopf, Julian, et al.
Publicado: (2020)

MicroRNA profile for health risk assessment: Environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery
por: Krauskopf, Julian, et al.
Publicado: (2017)

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits
por: Wiels, Wietse A., et al.
Publicado: (2021)

Blood Erythrocyte Concentrations of Cadmium and Lead and the Risk of B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma: A Nested Case-Control Study
por: Kelly, Rachel S., et al.
Publicado: (2013)

Omics for prediction of environmental health effects: Blood leukocyte-based cross-omic profiling reliably predicts diseases associated with tobacco smoking
por: Georgiadis, Panagiotis, et al.
Publicado: (2016)

Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis
por: Georgiadis, Panagiotis, et al.
Publicado: (2017)

Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases
por: Chatziioannou, Aristotelis, et al.
Publicado: (2017)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage
por: Vlaanderen, Jelle, et al.
Publicado: (2017)

Callosal circularity as an early marker for Alzheimer's disease
por: Van Schependom, Jeroen, et al.
Publicado: (2018)

Acetaminophen Overdose as a Potential Risk Factor for Parkinson's Disease
por: Bohler, Sacha, et al.
Publicado: (2019)

Prediagnostic plasma concentrations of organochlorines and risk of B-cell non-Hodgkin lymphoma in envirogenomarkers: a nested case-control study
por: Kelly, Rachel S., et al.
Publicado: (2017)

Inter- and Intra-Scanner Variability of Automated Brain Volumetry on Three Magnetic Resonance Imaging Systems in Alzheimer’s Disease and Controls
por: Wittens, Mandy Melissa Jane, et al.
Publicado: (2021)

Identification of Sex-Specific Transcriptome Responses to Polychlorinated Biphenyls (PCBs)
por: Espín-Pérez, Almudena, et al.
Publicado: (2019)

Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm
por: Struyfs, Hanne, et al.
Publicado: (2020)

DNA methylation profiling implicates exposure to PCBs in the pathogenesis of B-cell chronic lymphocytic leukemia()
por: Georgiadis, Panagiotis, et al.
Publicado: (2019)

Determinants of Erythrocyte Lead Levels in 454 Adults in Florence, Italy
por: Caini, Saverio, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)

Performance in Omics Analyses of Blood Samples in Long-Term Storage: Opportunities for the Exploitation of Existing Biobanks in Environmental Health Research
por: Hebels, Dennie G.A.J., et al.
Publicado: (2013)

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response
por: Duchateau, Lena, et al.
Publicado: (2023)

End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden
por: Sommar, Johan Nilsson, et al.
Publicado: (2013)

Melatonin levels in the Alzheimer’s disease continuum: a systematic review
por: Nous, Amber, et al.
Publicado: (2021)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
por: Temmerman, Joke, et al.
Publicado: (2023)

Predicting missing proteomics values using machine learning: Filling the gap using transcriptomics and other biological features
por: Ochoteco Asensio, Juan, et al.
Publicado: (2022)

Cancer Biomarkers from Genome-Scale DNA Methylation: Comparison of Evolutionary and Semantic Analysis Methods
por: Valavanis, Ioannis, et al.
Publicado: (2015)

Alzheimer’s disease CSF biomarkers: clinical indications and rational use
por: Niemantsverdriet, Ellis, et al.
Publicado: (2017)

Cardiovascular disease: The Brazilian research contribution
por: Krauskopf, Erwin
Publicado: (2019)

Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts
por: Berger, Eloise, et al.
Publicado: (2018)

Cognitive Writing Process Characteristics in Alzheimer’s Disease
por: Meulemans, Catherine, et al.
Publicado: (2022)

Correspondence on “Endocytosis-Mediated Transport of Pb in Rat Blood Cells”
por: Bergdahl, Ingvar A.
Publicado: (2023)

Stronger Correlations between Neurophysiological and Peripheral Disease Biomarkers Predict Better Prognosis in Two Severe Diseases
por: Gidron, Yori, et al.
Publicado: (2019)

Traditional Cardiovascular Risk Factors and Their Relation to Future Surgery for Valvular Heart Disease or Ascending Aortic Disease: A Case–Referent Study
por: Ljungberg, Johan, et al.
Publicado: (2017)

Brief cognitive screening instruments for early detection of Alzheimer’s disease: a systematic review
por: De Roeck, Ellen Elisa, et al.
Publicado: (2019)

FuSe: a tool to move RNA-Seq analyses from chromosomal/gene loci to functional grouping of mRNA transcripts
por: Gupta, Rajinder, et al.
Publicado: (2020)

Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds
por: Verheijen, Marcha, et al.
Publicado: (2022)

Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study
por: Wittens, Mandy Melissa Jane, et al.
Publicado: (2021)

Improved Preventive Effects of Combined Bioactive Compounds Present in Different Blueberry Varieties as Compared to Single Phytochemicals
por: van Breda, Simone G. J., et al.
Publicado: (2018)

A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
por: Ottoy, Julie, et al.
Publicado: (2017)

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease
por: Vermeiren, Yannick, et al.
Publicado: (2015)

Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease
por: Ljungberg, Johan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q990srdskkae4pepaphltc95kc